Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Oral Health Reports
Published in: Current Oral Health Reports 4/2017

Open Access 01-12-2017 | Epidemiology (M Laine, Section Editor)

Use of Probiotics and Oral Health

Authors: Robert P. Allaker, Abish S. Stephen

Published in: Current Oral Health Reports | Issue 4/2017

Login to get access

Abstract

Purpose of Review

The purpose of this study is to critically assess recent studies concerning the use of probiotics to control periodontal diseases, dental caries and halitosis (oral malodour).

Recent Findings

Clinical studies have shown that probiotics when allied to conventional periodontal treatment can ameliorate microbial dysbiosis and produce significant improvement in clinical indicators of disease. However, this effect is often not maintained by the host after the end of probiotic use. Current probiotics also show limited effects in treating caries and halitosis. Novel approaches based up on replacement therapy and using highly abundant health-associated oral species, including nitrate-reducing bacteria, have been proposed to improve persistence of probiotic strains and maintain oral health benefits.

Summary

Probiotics have potential in the management of multifactorial diseases such as the periodontal diseases and caries, by more effectively addressing the host-microbial interface to restore homeostasis that may not be achieved with conventional treatments.
Literature
1.
2.
3.
Devine DA, Marsh PD. Prospects for the development of probiotics and prebiotics for oral applications. J Oral Microbiol. 2009;1:1–11.CrossRef
4.
Meurman JH. Probiotics: do they have a role in oral medicine and dentistry? Eur J Oral Sci. 2005;113:188–96.CrossRefPubMed
5.
Devine DA, Marsh PD, Meade J. Modulation of host responses by oral commensal bacteria. J Oral Microbiol. 2015;7(1):26941.CrossRefPubMed
6.
Chapple ILC, et al. Interaction of lifestyle, behaviour or systemic diseases with dental caries and periodontal diseases: consensus report of group 2 of the joint EFP/ORCA workshop on the boundaries between caries and periodontal diseases. J Clin Periodontol. 2017;44:S39–51.CrossRefPubMed
7.
8.
9.
10.
Saha S, et al. Probiotics as oral health biotherapeutics. Expert Opin Biol Ther. 2012;12(9):1207–20.CrossRefPubMed
11.
Teughels W, Loozen G, Quirynen M. Do probiotics offer opportunities to manipulate the periodontal oral microbiota? J Clin Periodontol. 2011;38(SUPPL. 11):159–77.CrossRefPubMed
12.
Montero E et al. Clinical and microbiological effects of the adjunctive use of probiotics in the treatment of gingivitis: a randomized controlled clinical trial. J Clin Periodontol. 2017.
13.
Schlagenhauf U, et al. Regular consumption of Lactobacillus reuteri-containing lozenges reduces pregnancy gingivitis: an RCT. J Clin Periodontol. 2016;43(11):948–54.CrossRefPubMed
14.
Penala S, et al. Efficacy of local use of probiotics as an adjunct to scaling and root planing in chronic periodontitis and halitosis: a randomized controlled trial. J Res Pharm Pract. 2016;5(2):86–93.CrossRefPubMedPubMedCentral
15.
Morales A, et al. Clinical effects of Lactobacillus rhamnosus in non-surgical treatment of chronic periodontitis: a randomized placebo-controlled trial with 1-year follow-up. J Periodontol. 2016;87(8):944–52.CrossRefPubMed
16.
Iwasaki K, et al. Daily intake of heat-killed Lactobacillus plantarum L-137 decreases the probing depth in patients undergoing supportive periodontal therapy. Oral Health Prev Dent. 2016;14(3):207–14.PubMed
17.
Alkaya B, et al. Clinical effects of probiotics containing Bacillus species on gingivitis: a pilot randomized controlled trial. J Periodontal Res. 2016:497–504.
18.
Laleman I, et al. The effect of a streptococci containing probiotic in periodontal therapy: a randomized controlled trial. J Clin Periodontol. 2015;42(11):1032–41.CrossRefPubMed
19.
Tekce M, et al. Clinical and microbiological effects of probiotic lozenges in the treatment of chronic periodontitis: a 1-year follow-up study. J Clin Periodontol. 2015;42(4):363–72.CrossRefPubMed
20.
• Lee J-K, et al. Modulation of the host response by probiotic Lactobacillus brevis CD2 in experimental gingivitis. Oral Dis. 2015;21:705–12. Clinical study to demonstrate Lactobacillus brevis has anti-inflammatory properties by preventing nitric oxide synthesis.CrossRefPubMed
21.
Szkaradkiewicz AK, Stopa J, Karpiński TM. Effect of oral administration involving a probiotic strain of Lactobacillus reuteri on pro-inflammatory cytokine response in patients with chronic periodontitis. Arch Immunol Ther Exp. 2014;62(6):495–500.CrossRef
22.
Hallström H, et al. Effect of probiotic lozenges on inflammatory reactions and oral biofilm during experimental gingivitis. Acta Odontol Scand. 2013;71(3–4):828–33.CrossRefPubMed
23.
Teughels W, et al. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study. J Clin Periodontol. 2013;40(11):1025–35.CrossRefPubMedPubMedCentral
24.
Vicario M, et al. Clinical changes in periodontal subjects with the probiotic Lactobacillus reuteri Prodentis: a preliminary randomized clinical trial. Acta Odontol Scand. 2013;71:813–9.CrossRefPubMed
25.
Iniesta M, et al. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. a randomized clinical trial. J Clin Periodontol. 2012;39(8):736–44.CrossRefPubMed
26.
Slawik S, et al. Probiotics affect the clinical inflammatory parameters of experimental gingivitis in humans. Eur J Clin Nutr. 2011;65(7):857–63.CrossRefPubMed
27.
Vivekananda MR, Vandana KL, Bhat KG. Effect of the probiotic Lactobacilli reuteri (prodentis) in the management of periodontal disease: a preliminary randomized clinical trial. J Oral Microbiol. 2010;2:1–9.CrossRef
28.
Bidault P, Chandad F, Grenier D. Risk of bacterial resistance associated with systemic antibiotic therapy in periodontology. J Can Dent Assoc. 2007;73(8):721–5.PubMed
29.
Rams TE, Degener JE, van Winkelhoff AJ. Antibiotic resistance in human chronic periodontitis microbiota. J Periodontol. 2014;85(1):160–9.CrossRefPubMed
30.
Martin-Cabezas R, et al. Clinical efficacy of probiotics as an adjunctive therapy to non-surgical periodontal treatment of chronic periodontitis: a systematic review and meta-analysis. J Clin Periodontol. 2016;43(6):520–30.CrossRefPubMed
31.
• Gruner D, Paris S, Schwendicke F. Probiotics for managing caries and periodontitis: systematic review and meta-analysis. J Dent. 2016;48:16–25. Appraisal of clinical trials assessing probiotics to manage dental caries and the periodontal diseases.CrossRefPubMed
32.
Vuotto C, Longo F, Donelli G. Probiotics to counteract biofilm-associated infections: promising and conflicting data. Int J Oral Sci. 2014;6(4):189–94.CrossRefPubMedPubMedCentral
33.
34.
35.
36.
Toiviainen A, et al. Impact of orally administered lozenges with Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12 on the number of salivary mutans streptococci, amount of plaque, gingival inflammation and the oral microbiome in healthy adults. Clin Oral Investig. 2014;12:77–83.
37.
• Burton JP et al. Persistence of the Oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics. PLoS One. 2013;8(6). Study into increasing persistence of the highly abundant probiotic oral streptococcus, used in treating oral malodour and caries.
38.
• Vestman NR, et al. Oral microbiota shift after 12-week supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; a randomized control trial. PLoS One. 2015;10(5):1–18. High throughput sequencing study of community-wide changes in supragingival plaque microbiota with probiotic use, and follow up.
39.
Dongarrà ML, et al. Mucosal immunology and probiotics. Curr Allergy Asthma Rep. 2013;13(1):19–26.CrossRefPubMed
40.
Ku S, et al. Review on Bifidobacterium bifidum bgn4: functionality and nutraceutical applications as a probiotic microorganism. Int J Mol Sci. 2016;17(9):1544.CrossRefPubMedCentral
41.
Kobayashi R, et al. Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis-accelerated periodontal disease. Sci Rep. 2017;7(1):545.CrossRefPubMedPubMedCentral
42.
McCabe L, Britton RA, Parameswaran N. Prebiotic and probiotic regulation of bone health: role of the intestine and its microbiome. Curr Osteoporos Rep. 2015;13(6):363–71.CrossRefPubMedPubMedCentral
43.
Pazzini CA, et al. Probiotic consumption decreases the number of osteoclasts during orthodontic movement in mice. Arch Oral Biol. 2017;79:30–4.CrossRefPubMed
44.
İnce G, et al. Clinical and biochemical evaluation of Lactobacillus reuteri containing lozenges as an adjunct to non-surgical periodontal therapy in chronic periodontitis. J Periodontol. 2015;86(6):1–13.
45.
Oliveira LFF, et al. Benefits of Bifidobacterium animalis subsp lactis probiotic in experimental periodontitis. J Periodontol. 2017;88(2):197–208.CrossRefPubMed
46.
Messora MR, et al. Favourable effects of Bacillus subtilis and Bacillus licheniformis on experimental periodontitis in rats. Arch Oral Biol. 2016;66:108–19.CrossRefPubMed
47.
Foureaux RDC, et al. Effects of probiotic therapy on metabolic and inflammatory parameters of rats with ligature-induced periodontitis associated with restraint stress. J Periodontol. 2014;85(7):975–83.CrossRef
48.
Maekawa T, Hajishengallis G. Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss. J Periodontal Res. 2014;49(6):785–91.CrossRefPubMedPubMedCentral
49.
50.
Bene KP, et al. Lactobacillus reuteri surface mucus adhesins upregulate inflammatory responses through interactions with innate C-Type lectin receptors. Front Microbiol. 2017;8:321.CrossRefPubMedPubMedCentral
51.
Godoy L, et al. The probiotic mixture VSL#3 alters the morphology and secretion profile of both polarized and unpolarised human macrophages in a polarization-dependent manner. J Clin Cell Immunol. 2014;5(3)
52.
Scully C, Greenman J. Halitosis (breath odor). Periodontol. 2008;48:66–75.CrossRef
53.
54.
Allaker RP, et al. Topographic distribution of bacteria associated with oral malodour on the tongue. Arch Oral Biol. 2008;53(Suppl 1):S8–12.CrossRefPubMed
55.
56.
Eren a M, et al. Oligotyping analysis of the human oral microbiome. Proc Natl Acad Sci. 2014;111:2875–84.CrossRef
57.
Wescombe PA, et al. Something old and something new: an update on the amazing repertoire of bacteriocins produced by Streptococcus salivarius. Probiotics Antimicrob Proteins. 2010;2(1):37–45.CrossRefPubMed
58.
Horz HP, et al. Distribution and persistence of probiotic Streptococcus salivarius K12 in the human oral cavity as determined by real-time quantitative polymerase chain reaction. Oral Microbiol Immunol. 2007;22(2):126–30.CrossRefPubMed
59.
Burton JP, et al. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol. 2006;100(4):754–64.CrossRefPubMed
60.
Masdea L, et al. Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour. Arch Oral Biol. 2012;57(8):1041–7.CrossRefPubMed
61.
Iwamoto T, et al. Effects of probiotic Lactobacillus salivarius WB21 on halitosis and oral health: An open-label pilot trial. Oral Surgery, Oral Med Oral Pathol Oral Radiol. Endodontology. 2010;110(2):201–8.
62.
Suzuki N, et al. Lactobacillus salivarius WB21-containing tablets for the treatment of oral malodor: a double-blind, randomized, placebo-controlled crossover trial. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(4):462–70.CrossRefPubMed
63.
Jang HJ, et al. Comparative study on the characteristics of Weissella cibaria CMU and probiotic strains for oral care. Molecules. 2016;21(12)
64.
Suzuki N et al. Inhibitory effect of enterococcus faecium wb2000 on volatile sulfur compound production by porphyromonas gingivalis. Int J Dent. 2016.
65.
Lee S-H, Baek D-H. Effects of Streptococcus thermophilus on volatile sulfur compounds produced by Porphyromonas gingivalis. Arch Oral Biol. 2014;59(11):1205–10.CrossRefPubMed
66.
Fujiwara N, et al. Novel reuterin-related compounds suppress odour by periodontopathic bacteria. Oral Dis. 2017;23(4):492–7.CrossRefPubMed
67.
Keller MK, et al. Effect of chewing gums containing the probiotic bacterium Lactobacillus reuteri on oral malodour. Acta Odontol Scan. 2012;70(3):246–50.CrossRef
68.
Marchetti E, et al. Multi-sensor approach for the monitoring of halitosis treatment via Lactobacillus brevis (CD2)-containing lozenges—a randomized, double-blind placebo-controlled clinical trial. Sensors (Basel). 2015;15(8):19583–96.CrossRef
69.
Sutula J, et al. The effect of a commercial probiotic drink containing Lactobacillus casei strain Shirota on oral health in healthy dentate people. Microb Ecol Health Dis. 2013;24:1–12.
70.
Terai T, et al. Screening of probiotic candidates in human oral bacteria for the prevention of dental disease. PLoS One. 2015;10(6):1–20.CrossRef
71.
Mancinelli RL, McKay CP. Effects of nitric oxide and nitrogen dioxide on bacterial growth. Appl Environ Microbiol. 1983;46:198–202.PubMedPubMedCentral
72.
• Kilian M, et al. The oral microbiome—an update for oral healthcare professionals. Brit Dent J. 2016;221:657–66. Current knowledge of the oral microbiome in health and disease. Discussion on the implications for oral health care.CrossRefPubMed
73.
Lundberg JO, et al. Nitrate, bacteria and human health. Nat Rev (Microbiol). 2004;2:1–10.CrossRef
74.
Doel JJ, et al. Evaluation of bacterial nitrate reduction in the human oral cavity. Eur J Oral Sci. 2005;113:14–9.CrossRefPubMed
75.
76.
Silva Mendez LS. Antimicrobial effect of acidified nitrite on cariogenic bacteria. Oral Microbiol Immunol. 1999;14:391–2.CrossRefPubMed
77.
Doel JJ. Protective effect of salivary nitrate and microbial nitrate reductase activity against caries. Euro. J Oral Sci. 2004;112:424–8.CrossRef
78.
Stephen AS, et al. The role of periodontal niches in influencing the tongue microbiota: relationship with periodontitis and oral malodour. J Oral Microbiol. 2017;9((1)Sup1):1325201.CrossRefPubMedCentral
79.
• Qu XM, et al. From nitrate to nitric oxide: the role of salivary glands and oral bacteria. J Dent Res. 2016;95(13):1452–6. Review describing role of saliva and oral bacteria in nitrate metabolism and maintenance of nitric oxide homeostasis.CrossRefPubMed
80.
Hussain QA, et al. Detection of adrenomedullin and nitric oxide in different forms of periodontal disease. J Perio Res. 2016;5:16–25.CrossRef
81.
Hussain QA, et al. Regulation of adrenomedullin and nitric oxide production by periodontal bacteria. J Perio Res. 2015;50:650–7.CrossRef
82.
83.
Haukioja A. Probiotics and oral health. Euro. J Dent. 2010;4:348–55.
84.
Zahradnik RT, et al. Preliminary assessment of safety and effectiveness in humans of ProBiora3, a probiotic mouthwash. J Appl Microbiol. 2009;107:682–90.CrossRefPubMed
85.
Pierro D, et al. Cariogram outcome after 90 days of oral treatment with Streptococcus salivarius M18 in children at high risk for dental caries: results of a randomized, controlled study. Clin Cosmet Invest Dent. 2015;7:107–13.CrossRef
86.
Hillman JD, et al. Construction and characterization of an effector strain of Streptococcus mutans for replacement therapy of dental caries. Infect Immun. 2000;68:543–9.CrossRefPubMedPubMedCentral
87.
Pozhitkov AE, et al. Towards microbiome transplant as a therapy for periodontitis: an exploratory study of periodontitis microbial signature contrasted by oral health, caries and edentulism. BMC Oral Health. 2015;15:125.CrossRefPubMedPubMedCentral
Metadata
Title
Use of Probiotics and Oral Health
Authors
Robert P. Allaker
Abish S. Stephen
Publication date
01-12-2017
Publisher
Springer International Publishing
Published in
Current Oral Health Reports / Issue 4/2017
Electronic ISSN: 2196-3002
DOI
https://doi.org/10.1007/s40496-017-0159-6

Other articles of this Issue 4/2017

Current Oral Health Reports 4/2017 Go to the issue

Epidemiology (M Laine, Section Editor)

Proteomics of Periodontal Pocket

Epidemiology (M Laine, Section Editor)

Current Concepts of Epigenetics and Its Role in Periodontitis

Epidemiology (M Laine, Section Editor)

Periodontitis: from Infection to Inflammation

Epidemiology (M Laine, Section Editor)

Definitions and Epidemiology of Endodontic Infections

Epidemiology (M Laine, Section Editor)

Periodontal Abscess: a Review and the Role of Antimicrobial Therapy

Dental Stem Cells in Tissue Regeneration (F Setzer, Section Editor)

Revascularization of Immature Necrotic Teeth